CC
ACLX

CIBRA Capital’s Arcellx ACLX Stock Holding History

CIBRA Capital’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2M Buy
+88,623
New +$7.82M 4.91% 10

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

CIBRA Capital's ACLX Position: Q1 2026 in Review

CIBRA Capital opened a new position in Arcellx (ACLX) in Q1 2026: 88,623 shares worth $10.2M. The stake represents 4.91% of the portfolio and ranks #10 among its holdings.

240 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • CIBRA Capital held 88,623 shares of Arcellx worth $10.2M as of Q1 2026.
  • Arcellx was a new CIBRA Capital position in Q1 2026.
  • Arcellx made up 4.91% of CIBRA Capital's portfolio in Q1 2026, its #10 holding.
  • 240 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on CIBRA Capital's 13F filing for Q1 2026, filed 24 Apr 2026.